This story has been updated with additional comments from Datavant. Health tech company Datavant is making moves to be a bigger player in the real-world data space. The company announced Thursday that ...

Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...

Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster presentations highlighting real-world ...

With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals. CAMBRIDGE, Mass., Oct. 15, 2025 ...

Venetoclax shows similar efficacy and safety in real-world settings and clinical trials for CLL treatment, with a 94% overall response rate. Real-world studies provide insights into diverse patient ...

Until recently, the most effective protection against respiratory syncytial virus (RSV) was only available for high-risk infants, and many parents and providers may remember the vulnerability that ...

In this episode we are joined by Eric Fontana, VP of Client Solutions at Optum Life Sciences; Bethany Kalich, U.S. Medical Director, Cardiovascular at Amgen; and Christen Buseman, Director, IDN ...

When robotics and cloud-connected digital twins work in sync, they create a living, responsive system that continually ...